Next Generation of Neurological Therapeutics: Native and Bioengineered Extracellular Vesicles Derived from Stem Cells

Overview

Journal Asian J Pharm Sci

Date 2023 Jan 5

PMID 36600903

Authors

Shilin Jin

Zhongyue Lv

Lin Kang

Jiayi Wang

Chengcheng Tan

Liming Shen

Liang Wang

Jing Liu

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs)-based cell-free therapy, particularly stem cell-derived extracellular vesicles (SC-EVs), offers new insights into treating a series of neurological disorders and becomes a promising candidate for alternative stem cell regenerative therapy. Currently, SC-EVs are considered direct therapeutic agents by themselves and/or dynamic delivery systems as they have a similar regenerative capacity of stem cells to promote neurogenesis and can easily load many functional small molecules to recipient cells in the central nervous system. Meanwhile, as non-living entities, SC-EVs avoid the uncontrollability and manufacturability limitations of live stem cell products (, low survival rate, immune response, and tumorigenicity) and (, restricted sources, complex preparation processes, poor quality control, low storage, shipping instability, and ethical controversy) by strict quality control system. Moreover, SC-EVs can be engineered or designed to enhance further overall yield, increase bioactivity, improve targeting, and extend their half-life. Here, this review provides an overview on the biological properties of SC-EVs, and the current progress in the strategies of native or bioengineered SC-EVs for nerve injury repairing is presented. Then we further summarize the challenges of recent research and perspectives for successful clinical application to advance SC-EVs from bench to bedside in neurological diseases.

Citing Articles

A self-adjuvant multiantigenic nanovaccines simultaneously activate the antiviral and antitumor immunity for the treatment of cancers.

Wang Z, Chen H, Ming R, Wang W, Liu S, Jing Y J Nanobiotechnology. 2025; 23(1):150.

PMID: 40016753 PMC: 11866856. DOI: 10.1186/s12951-025-03208-1.

From mesenchymal stem cells to their extracellular vesicles: Progress and prospects for asthma therapy.

Chen S, Gao J, Zhang T Asian J Pharm Sci. 2024; 19(4):100942.

PMID: 39253613 PMC: 11382190. DOI: 10.1016/j.ajps.2024.100942.

Novel Therapeutic Mechanisms and Strategies for Intracerebral Hemorrhage: Focusing on Exosomes.

Jiang S, Hu L, Zhou H, Wu J, Zhou J, Yu X Int J Nanomedicine. 2024; 19:8987-9007.

PMID: 39246427 PMC: 11378801. DOI: 10.2147/IJN.S473611.

Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases.

Su Y, Chen M, Xu W, Gu P, Fan X ACS Nano. 2024; 18(34):22793-22828.

PMID: 39141830 PMC: 11363148. DOI: 10.1021/acsnano.4c08486.

Extracellular vesicles: Function, resilience, biomarker, bioengineering, and clinical implications.

Sun D, Chang H Tzu Chi Med J. 2024; 36(3):251-259.

PMID: 38993825 PMC: 11236075. DOI: 10.4103/tcmj.tcmj_28_24.

References

Cao J, Wang B, Tang T, Lv L, Ding Z, Li Z . Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury. Stem Cell Res Ther. 2020; 11(1):206. PMC: 7251891. DOI: 10.1186/s13287-020-01719-2. View

Macpherson A, Kimmelman J . Ethical development of stem-cell-based interventions. Nat Med. 2019; 25(7):1037-1044. DOI: 10.1038/s41591-019-0511-6. View

Kim Y, Kim J, Cho R, Shin D, Lee S, Oh Y . Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway. Exp Mol Med. 2017; 49(1):e284. PMC: 5291836. DOI: 10.1038/emm.2016.127. View

Thomi G, Surbek D, Haesler V, Joerger-Messerli M, Schoeberlein A . Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury. Stem Cell Res Ther. 2019; 10(1):105. PMC: 6429800. DOI: 10.1186/s13287-019-1207-z. View

Mendt M, Kamerkar S, Sugimoto H, McAndrews K, Wu C, Gagea M . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018; 3(8). PMC: 5931131. DOI: 10.1172/jci.insight.99263. View

Kim H, Choi D, Yun S, Choi S, Kang J, Jung J . Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2011; 11(2):839-49. DOI: 10.1021/pr200682z. View

Xin H, Wang F, Li Y, Lu Q, Cheung W, Zhang Y . Secondary Release of Exosomes From Astrocytes Contributes to the Increase in Neural Plasticity and Improvement of Functional Recovery After Stroke in Rats Treated With Exosomes Harvested From MicroRNA 133b-Overexpressing Multipotent Mesenchymal.... Cell Transplant. 2016; 26(2):243-257. PMC: 5303172. DOI: 10.3727/096368916X693031. View

Xiong L, Sun L, Zhang Y, Peng J, Yan J, Liu X . Exosomes from Bone Marrow Mesenchymal Stem Cells Can Alleviate Early Brain Injury After Subarachnoid Hemorrhage Through miRNA129-5p-HMGB1 Pathway. Stem Cells Dev. 2019; 29(4):212-221. DOI: 10.1089/scd.2019.0206. View

Moon G, Sung J, Kim D, Kim E, Cho Y, Son J . Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study. Transl Stroke Res. 2018; 10(5):509-521. DOI: 10.1007/s12975-018-0668-1. View

10.

Zhou X, Chu X, Yuan H, Qiu J, Zhao C, Xin D . Mesenchymal stem cell derived EVs mediate neuroprotection after spinal cord injury in rats via the microRNA-21-5p/FasL gene axis. Biomed Pharmacother. 2019; 115:108818. DOI: 10.1016/j.biopha.2019.108818. View

11.

Kim S, Maeng J, Hyun S, Sohn H, Kim S, Hong C . Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis. Theranostics. 2020; 10(11):5011-5028. PMC: 7163430. DOI: 10.7150/thno.42742. View

12.

Lazaro-Ibanez E, Faruqu F, Saleh A, Silva A, Wang J, Rak J . Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution . ACS Nano. 2021; 15(2):3212-3227. PMC: 7905875. DOI: 10.1021/acsnano.0c09873. View

13.

Xian P, Hei Y, Wang R, Wang T, Yang J, Li J . Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019; 9(20):5956-5975. PMC: 6735367. DOI: 10.7150/thno.33872. View

14.

Brennan M, Layrolle P, Mooney D . Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration. Adv Funct Mater. 2020; 30(37). PMC: 7494127. DOI: 10.1002/adfm.201909125. View

15.

Zheng X, Zhang L, Kuang Y, Venkataramani V, Jin F, Hein K . Extracellular Vesicles Derived from Neural Progenitor Cells--a Preclinical Evaluation for Stroke Treatment in Mice. Transl Stroke Res. 2020; 12(1):185-203. PMC: 7803677. DOI: 10.1007/s12975-020-00814-z. View

16.

Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L . Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy. Cell Death Dis. 2019; 10(5):340. PMC: 6472377. DOI: 10.1038/s41419-019-1571-8. View

17.

Xin H, Li Y, Cui Y, Yang J, Zhang Z, Chopp M . Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013; 33(11):1711-5. PMC: 3824189. DOI: 10.1038/jcbfm.2013.152. View

18.

Qin S, Zou Y, Zhang C . Cross-talk between KLF4 and STAT3 regulates axon regeneration. Nat Commun. 2013; 4:2633. PMC: 3867821. DOI: 10.1038/ncomms3633. View

19.

Kim H, Kumar H, Jo M, Kim J, Yoon J, Lee J . Therapeutic Efficacy-Potentiated and Diseased Organ-Targeting Nanovesicles Derived from Mesenchymal Stem Cells for Spinal Cord Injury Treatment. Nano Lett. 2018; 18(8):4965-4975. DOI: 10.1021/acs.nanolett.8b01816. View

20.

Yu L, Gui S, Liu Y, Qiu X, Zhang G, Zhang X . Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Aging (Albany NY). 2019; 11(15):5300-5318. PMC: 6710058. DOI: 10.18632/aging.102092. View